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INTRODUCTION
Colorectal cancer (CRC) is known to be associated with a wide range of procoagulant and fibrinolytic disorders mainly due to its prothrombotic tendency and increased fibrinolytic capacity (1). D-dimer (DD) is a sensitive marker of fibrinolysis whose levels are frequently elevated in patients with malignancies, especially solid tumors such as colorectal, lung, prostate and gynecological cancers (2-7), as well as patients with particular nonmalignant conditions (8).
Although high preoperative DD levels appeared to correlate with advanced tumor stage, lymph node involvement, lymphatic and venous invasion and poor long-term outcome in several series of CRC patients (3, (9) (10) (11) (12) (13) , DD's clinical applicability as a tumor marker remains ill defined. progression as well as survival and was eventually used in the analysis. Preoperative CEA levels higher than 3.5 ng/mL were considered positive, in accordance with the manufacturer's instructions. To evaluate the significance of differences between DD-and CEApositive and negative cases, the chi-square test was used for categorical data and Student's t-test for continuous variables. In order to establish the possible correlation between DD and CEA levels, linear regression analysis was performed after logarithmic transformation of the values of both markers.
Survival analysis was computed using the Kaplan-Meier method and compared using the log-rank test, with time of survival measured from the date of surgery to the date of death or most recent follow-up. Multivariate analysis was performed by the Cox regression model, taking into account the following risk factors: age (higher than median vs median or below), sex (male vs female), tumor location (rectum vs colon), resection category (R1-2 vs R0), tumor stage (Dukes B, C and D vs Dukes A), grading (G3-4 vs G1-2), preoperative CEA levels (>3.5 ng/ mL vs ≤3.5 ng/mL) and preoperative DD levels (>250 ng/ mL vs ≤250 ng/mL).
Analyses were performed using the Statistical Package for the Social Sciences, SPSS 16.0 for Windows (SPSS Inc., Chicago, IL, USA).
RESULTS

D-dimer and clinicopathological variables
The preoperative mean (± SD) value of DD was 347.5 (± 940.1) ng/mL (median: 194; range: 42-12,727 ng/mL).
The clinicopathological data in relation to preoperative DD levels are reported in Table I . With regard to tumor location, patients with colon cancer showed a higher rate of DD levels >250 ng/mL than patients with rectal cancer (43.3% vs 29.3%), but the difference was not statistically significant (p=0.079). A DD value >250 ng/mL was observed more frequently in patients who underwent emergency surgery (p=0.002) and patients who had residual tumor after surgical resection (p=0.037). When only patients who underwent elective surgery were considered, a preoperative positive DD value (>250 ng/ mL) was observed in 30.9% of patients who received a potentially curative (R0) resection and in 50% of patients with residual tumor (p=0.035).
Higher DD levels were also observed in patients with pT3 and pT4 tumors compared with patients having tumor invasion limited to the muscularis propria (pT1-2 vs pT3-4: 23.3% and 43.6%, respectively; p=0.021) ( Fig. 1) . Similarly, a significant correlation was observed between plasma DD value and mean tumor diameter (p<0.001). When tumors <3 cm, tumors 3-5 cm, and tumors >5 cm
Preoperative workup and pathological staging
On admission, all patients underwent preoperative staging by means of colonoscopy, abdominal ultrasonography and CT scan. Besides the routine laboratory tests, tumor markers (CEA, , coagulation screen, and plasma DD levels were determined.
The resected specimens were examined by routine histopathological analysis and tumor stage was determined according to the criteria established by the American Joint Committee on Cancer (AJCC) and the Union International Contre le Cancer (UICC) together with the Dukes classification. Tumor diameter and differentiation as well as lymphatic and vascular invasion were also evaluated.
Preoperative DD and CEA measurement
Whole blood samples were collected from the antecubital vein using a Vacutainer collection tube and sent to the hospital central laboratory for serum CEA and plasma DD measurement. Serum CEA was measured using the electrochemiluminescence immunoassay on the Roche modular analytics E170 (Elecsys module) immunoassay analyzer (Roche Diagnostics, Mannheim, Germany). Plasma DD was measured using the latexenhanced turbidimetric test D-Dimer PLUS (Dade Behring, Marburg, Germany) on the Dade Behring BCS analyzer.
Surgical technique
The main goal of surgery was complete removal of the tumor (R0 resection), although also palliative procedures were carried out to treat tumor-related complications. The type of resection was chosen on the basis of patient performance status, tumor location and stage. Standard right and left hemicolectomy, low or very low anterior resection, or transverse colon resection were carried out with vessel ligation; surgical oncological criteria were strictly adhered to in all procedures.
Follow-up and statistical analysis
All clinical and pathological data were retrospectively collected and stored in a database. The variables to be analyzed included demographic, clinical, surgical and pathological characteristics. An analysis of patient survival was carried out in June 2009 by collecting follow-up data during outpatient clinical examination and contacting the patients' family physicians.
At the preliminary analysis, preoperative DD levels were not normally distributed in the patient cohort. Different cutoff levels were therefore considered to study potential correlations with clinicopathological factors. The level recommended by the manufacturer (250 ng/mL) proved to be most closely related to tumor were considered separately, a positive DD value was observed in 26%, 41% and 58% of cases, respectively (p=0.003).
No differences in DD levels were observed related to age, sex, tumor grading, vascular invasion, nodal involvement, presence of systemic metastasis, and Dukes stage.
CEA and clinicopathological variables
The mean CEA (± SD) value was 106.4 (± 1099.2) ng/ mL (median: 3.5; range: 0.1-15,465 ng/mL).
Preoperative levels of CEA exceeded the cutoff value significantly more frequently in patients with metastatic disease (p<0.001), palliative resection (p<0.001), advanced stage according to the Dukes classification (p<0.001), advanced pT stage (p=0.016) and advanced pN stage (p=0.004).
CEA levels were not correlated with age, sex, tumor location, nature of surgery (emergency vs elective), tumor grading or vascular invasion.
Correlation between preoperative DD and CEA levels
A significant correlation was demonstrated between preoperative levels of DD and CEA. A DD level >250 ng/mL was observed in 38.5% of cases with CEA levels ≤3.5 ng/mL and in 61.5% with CEA levels >3.5 ng/mL (p=0.009). The graphic correlation between CEA and DD is depicted in Figure 2 . events, myocardial infarction, and veno-occlusive crisis in sickle-cell disease as well as in patients with neoplastic diseases (14-17). Experimental and clinical data have shown that coagulation disorders are common in patients with cancer. Patients diagnosed with malignancies are known to have an 11% lifetime risk of thromboembolic events given that solid tumors generally cause a prothrombotic tendency (1). A possible compensatory increase in global fibrinolytic capacity has also been described. Ozturk et al hypothesized that fibrinolytic activity in solid malignancies may help rapid dissolution of tumorassociated microthrombosis and cause increased fibrin degradation products such as DD (1).
DD levels have been widely reported to be elevated in patients with solid tumors including lung (4, 18, 19) , prostate (5), gynecological (6, 7, 20) , and colorectal cancer (3, (9) (10) (11) (12) (13) 21) . Even though activation of coagulation and fibrinolysis is known to be frequently associated with malignancies, the underlying mechanism has not been fully clarified. Fibrin turnover in the extracellular matrix of tumors is essential for angiogenesis and growth (22, 23) . Cross-linked fibrin in the extracellular matrix serves as a stable framework to endothelial cell migration during tumor angiogenesis and invasion. The process of tumor growth and metastasis requires a number of steps within a favorable host environment. In order to survive, metastatic cancer cells must leave the primary tumor, migrate into the lymphovascular system, and establish a new blood supply at their metastatic site (11). Fibrin remodeling is involved in many steps of the metastatic process and has been proven to play a crucial role in the formation of new
Survival according to DD and CEA levels
The overall 5-year survival rate for the whole group was 73.6%. Survival curves according to preoperative DD levels are reported in Figure 3 . The 5-year survival rate was 80% for patients with values <250 ng/mL and 64% for patients with values ≥250 ng/mL (p=0.156). Figure  4 shows the survival curves according to preoperative CEA values. A significantly worse long-term prognosis was observed for patients with CEA levels >3.5 ng/mL (p<0.001). Figure 5 shows the survival curves according to preoperative DD levels in patients with CEA above (B) and below (A) the cutoff value. Interestingly, the survival curves proved to be almost identical. These results were validated by multivariate analysis, where preoperative CEA level was confirmed to be an independent prognostic factor (p=0.005), whilst DD level was not (p=0.796).
DISCUSSION
D-dimer is a stable end product of fibrin degradation and its levels are elevated in situations of enhanced fibrin formation and fibrinolysis. It is a marker of hypercoagulation and has proved useful in detecting the existence of subclinical hypercoagulability in the absence of any other abnormalities of established parameters such as thrombin time, prothrombin time, activated partial thromboplastin time, and antithrombin III activity. Elevated DD levels have been detected in patients with disseminated intravascular coagulation, thromboembolic . Fig. 4 -Kaplan-Meier estimates of survival probability according to CEA serum levels in the 199 patients under study. cutoff value for DD and the mean value computed by 2-way analysis of variance after logarithmic conversion to a normal distribution (data not shown). Our data seem to suggest that DD levels are related to tumor bulk and size more than to tumor aggressiveness. By contrast, CEA levels were significantly related to all major prognostic factors: presence of metastases, residual tumor, and advanced pT, pN and Dukes stages.
Finally, when we looked at the prognostic value of preoperative DD levels, CEA clearly showed a closer correlation with long-term outcome, as demonstrated by overlapping survival curves in DD-positive and negative patients when stratified according to positivity for CEA ( Fig. 5) .
In conclusion, the present cohort represents the largest series of CRC patients in whom the preoperative value of DD has been tested as a new prognostic marker. The possible clinical usefulness suggested by previous studies has not been confirmed by our data. Conversely, CEA was confirmed to be the most reliable and valid indicator of prognosis. (24, 25) . Interestingly, plasminogen knockout mice models have revealed the importance of fibrin remodeling in tumor growth and metastasis. Mice that are deficient in the plasminogen gene usually develop larger tumors, have more distant metastases and decreased survival compared with their wild-type counterparts (26).
Preoperative DD levels have been taken into consideration as a diagnostic and prognostic marker in several gastrointestinal malignancies. A correlation between elevated DD levels and clinicopathological findings indicative of a poor prognosis has been pointed out in esophageal (27), gastric (28) and colorectal cancer (3, (9) (10) (11) (12) (13) 21) .
With regard to CRC, DD has been presented as an innovative marker by several authors, although only small series have been published so far (3, (9) (10) (11) (12) (13) 21) . The largest surgical series included analysis of 93 patients from Japan. The preoperative levels of DD were found to be related to tumor diameter, depth of tumor invasion (pT), pTNM stage, tumor grading, and lymphatic invasion. Furthermore, a significantly worse prognosis was observed in patients with a DD level in the fourth interquartile range (10). Similar findings have been reported by other authors in resectable (3, 9, 11, 12) as well as metastatic CRC (13).
In our study, a positive DD value (>250 ng/mL) was frequently observed in patients who underwent emergency or palliative surgery and higher levels were observed in patients with large tumors invading beyond the serosal layer. No association was seen with age, sex, pT, pN and M stages, Dukes classification, vascular invasion and tumor grading, both with respect to the A B 
